Documents
Application Sponsors
ANDA 079244 | LANNETT CO INC | |
Marketing Status
Application Products
001 | CONCENTRATE;ORAL | 2MG/ML | 0 | LORAZEPAM | LORAZEPAM |
FDA Submissions
| ORIG | 1 | AP | 2009-04-28 | |
LABELING; Labeling | SUPPL | 5 | AP | 2016-07-06 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
LANNETT CO INC
cder:Array
(
[0] => Array
(
[ApplNo] => 79244
[companyName] => LANNETT CO INC
[docInserts] => ["",""]
[products] => [{"drugName":"LORAZEPAM","activeIngredients":"LORAZEPAM","strength":"2MG\/ML","dosageForm":"CONCENTRATE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"04\/28\/2009","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/079244lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"LORAZEPAM","submission":"LORAZEPAM","actionType":"2MG\/ML","submissionClassification":"CONCENTRATE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 2009-04-28
)
)